IL273204A - Use of IL-1B binding antibodies to treat alcoholic jaundice - Google Patents
Use of IL-1B binding antibodies to treat alcoholic jaundiceInfo
- Publication number
- IL273204A IL273204A IL273204A IL27320420A IL273204A IL 273204 A IL273204 A IL 273204A IL 273204 A IL273204 A IL 273204A IL 27320420 A IL27320420 A IL 27320420A IL 273204 A IL273204 A IL 273204A
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- binding antibodies
- alcoholic hepatitis
- hepatitis
- alcoholic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/245—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762557929P | 2017-09-13 | 2017-09-13 | |
| US201862647088P | 2018-03-23 | 2018-03-23 | |
| PCT/IB2018/056928 WO2019053591A1 (en) | 2017-09-13 | 2018-09-11 | USE OF IL-1B BINDING ANTIBODIES FOR THE TREATMENT OF ALCOHOLIC HEPATITIS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL273204A true IL273204A (en) | 2020-04-30 |
Family
ID=63708416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL273204A IL273204A (en) | 2017-09-13 | 2020-03-10 | Use of IL-1B binding antibodies to treat alcoholic jaundice |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20200207848A1 (enExample) |
| EP (1) | EP3717006A1 (enExample) |
| JP (1) | JP2020533353A (enExample) |
| KR (1) | KR20200052331A (enExample) |
| CN (1) | CN111315412A (enExample) |
| AU (1) | AU2018333106A1 (enExample) |
| BR (1) | BR112020004903A2 (enExample) |
| CA (1) | CA3075711A1 (enExample) |
| CL (1) | CL2020000631A1 (enExample) |
| IL (1) | IL273204A (enExample) |
| MX (1) | MX2020002813A (enExample) |
| RU (1) | RU2020113234A (enExample) |
| TW (1) | TW201920269A (enExample) |
| WO (1) | WO2019053591A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026145640A1 (zh) * | 2025-01-03 | 2026-07-09 | 长春金赛药业有限责任公司 | 一种抗IL-1β抗体的药物组合物及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0020685D0 (en) * | 2000-08-22 | 2000-10-11 | Novartis Ag | Organic compounds |
| ES2335232T3 (es) | 2005-06-21 | 2010-03-23 | Xoma Technology Ltd. | Anticuerpos y fragmentos de los mismos que se unen a la il-1 beta. |
| EP2196476A1 (en) * | 2008-12-10 | 2010-06-16 | Novartis Ag | Antibody formulation |
| AU2010306681A1 (en) * | 2009-10-15 | 2012-04-19 | Abbvie Inc. | IL-1 binding proteins |
| US10000565B2 (en) * | 2012-11-16 | 2018-06-19 | Novartis Ag | Use of IL-1 β binding antibodies for treating peripheral arterial disease |
| WO2015083120A1 (en) * | 2013-12-04 | 2015-06-11 | Novartis Ag | USE OF IL-1β BINDING ANTIBODIES |
| MX2016014731A (es) * | 2014-05-12 | 2017-05-04 | Conatus Pharmaceuticals Inc | Tratamiento de las complicaciones de la enfermedad cronica del higado con enfermedades de caspasa. |
| KR101695848B1 (ko) * | 2015-03-03 | 2017-01-13 | 한국과학기술원 | 진세노사이드 f2를 포함하는 비알코올성 간 질환 또는 인슐린 저항성의 예방 또는 치료용 조성물 |
-
2018
- 2018-09-11 RU RU2020113234A patent/RU2020113234A/ru unknown
- 2018-09-11 WO PCT/IB2018/056928 patent/WO2019053591A1/en not_active Ceased
- 2018-09-11 MX MX2020002813A patent/MX2020002813A/es unknown
- 2018-09-11 JP JP2020514915A patent/JP2020533353A/ja not_active Withdrawn
- 2018-09-11 US US16/646,608 patent/US20200207848A1/en not_active Abandoned
- 2018-09-11 CA CA3075711A patent/CA3075711A1/en not_active Abandoned
- 2018-09-11 EP EP18779453.2A patent/EP3717006A1/en not_active Withdrawn
- 2018-09-11 AU AU2018333106A patent/AU2018333106A1/en not_active Abandoned
- 2018-09-11 BR BR112020004903-4A patent/BR112020004903A2/pt not_active Application Discontinuation
- 2018-09-11 KR KR1020207009866A patent/KR20200052331A/ko not_active Withdrawn
- 2018-09-11 CN CN201880066309.7A patent/CN111315412A/zh active Pending
- 2018-09-13 TW TW107132268A patent/TW201920269A/zh unknown
-
2020
- 2020-03-10 IL IL273204A patent/IL273204A/en unknown
- 2020-03-11 CL CL2020000631A patent/CL2020000631A1/es unknown
-
2021
- 2021-06-16 US US17/348,926 patent/US20210309736A1/en not_active Abandoned
-
2023
- 2023-03-30 US US18/193,563 patent/US20230235043A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW201920269A (zh) | 2019-06-01 |
| WO2019053591A1 (en) | 2019-03-21 |
| JP2020533353A (ja) | 2020-11-19 |
| MX2020002813A (es) | 2020-07-21 |
| AU2018333106A1 (en) | 2020-04-02 |
| US20200207848A1 (en) | 2020-07-02 |
| CA3075711A1 (en) | 2019-03-21 |
| EP3717006A1 (en) | 2020-10-07 |
| US20230235043A1 (en) | 2023-07-27 |
| US20210309736A1 (en) | 2021-10-07 |
| RU2020113234A3 (enExample) | 2022-04-28 |
| CN111315412A (zh) | 2020-06-19 |
| CL2020000631A1 (es) | 2020-09-11 |
| RU2020113234A (ru) | 2021-10-13 |
| KR20200052331A (ko) | 2020-05-14 |
| BR112020004903A2 (pt) | 2020-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280780A (en) | Anti-TIGIT antibodies | |
| IL280013A (en) | Anti-IL36R antibodies | |
| IL265321A (en) | cd3 binding antibodies | |
| IL277559A (en) | Multispecific antibodies and their use | |
| IL291068A (en) | Anti-cd73 antibodies | |
| IL289112A (en) | Antibodies against tigit | |
| IL279352A (en) | IL-11RA antibodies | |
| IL278010A (en) | Antibodies to galectin 10 | |
| IL277030A (en) | Antibodies | |
| SG11202106171WA (en) | Anti-btla antibodies | |
| IL325567A (en) | Methods of treatment using anti-il-17a/f antibodies | |
| IL283948A (en) | Methods for treating depression | |
| IL284584A (en) | Anti-tigit antibodies | |
| IL267271A (en) | Antibodies against il-5 | |
| SG11202102114UA (en) | Anti-klrg1 antibodies | |
| SG11202008513WA (en) | De-immunised anti-erbb3 antibodies | |
| IL277056A (en) | Methods for purifying antibodies | |
| GB201917480D0 (en) | Antibodies | |
| GB201900732D0 (en) | Antibodies | |
| GB201806084D0 (en) | Antibodies | |
| IL289160A (en) | Anti-angpt2 antibodies | |
| PL4025612T3 (pl) | Przeciwciała anty-fukozylo-gm1 | |
| GB2598698B (en) | Affinity-maturated anti-ASICIa antibodies | |
| HK40031483A (en) | Use of il-1b binding antibodies for the treatment of alcoholic hepatitis | |
| GB201820547D0 (en) | Modified antibodies |